Humanized Mouse Model Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, France, China, Japan - Size and Forecast 2024-2028

Published: Nov 2023 Pages: 160 SKU: IRTNTR43762

Humanized Mouse Model Market 2024-2028

The global humanized mouse model market size is estimated to grow by USD 108.6 million at a CAGR of 10.22% between 2023 and 2028. 

Personalized medicine, also called precision medicine or individualized medicine, is an emerging field of medicine. It identifies specific biomarkers to assess the best treatment for each patient. Mice have been used to develop personalized medicine for cancer. patient's tumor is infused into multiple and identical mice, which have compromised immune systems. Each mouse receives a different therapy, and each therapy is then assessed. The therapy that reduces the tumor would then be directed to the patient. The growing demand for personalized medicine will increase the adoption of humanized mouse models. Hence, such factors are expected to drive the growth of the market during the forecast period.

Technavio has segmented the market into End-user, Product, and Geography

  • The end-user segment includes pharmaceutical and biotechnology companies, CROs, and academic and research institutions
  • The product segment includes genetically humanized mouse model and cell-based humanized mouse model
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Humanized Mouse Model Market During the Forecast Period?

To learn more about this report, Download Report Sample

Humanized Mouse Model Market Segmentation by End-user, Product, and Geography Analysis

End-user Analysis

Pharmaceutical and biotechnology companies

The market share growth by the pharmaceutical and biotechnology companies segment will be significant during the forecast period. Pharmaceutical and biotechnology companies use humanized mouse models to study human diseases and test potential treatments. In the pharmaceutical industry, humanized mouse models are used in the early stages of drug development to identify potential drug targets and test the safety and efficacy of new drugs.

Get a glance at the market contribution of various segments Download the PDF Sample

The pharmaceutical and biotechnology companies segment was valued at USD 47.54 million in 2018. In the biotechnology industry, humanized mouse models are used to develop and test new biologics, such as monoclonal antibodies and cell therapies. Furthermore, the use of humanized mouse models in the pharmaceutical and biotechnology industries has become increasingly important in recent years, as these models provide more accurate and predictive results compared to traditional animal models. Therefore, such factors are expected to drive the growth of the segment during the forecast period.=

Product Analysis

Genetically humanized mouse model

In genetically modified mouse models, a specific gene is removed or replaced. These models are effective tools for several applications in molecular research and drug discovery. Due to the growth of the global molecular and genetic research industries, the adoption of genetically humanized mouse models is anticipated to increase. Furthermore, market players have streamlined the genetic engineering process in-house. Hence, ready-to-use mouse models are available for researchers. Product innovations have enabled researchers to choose disease-specific mouse models. Therefore, such factors are expected to drive the growth of this segment of the market during the forecast period.

Cell-based humanized mouse model

Cell-based humanized mouse models are structured differently when compared with genetically humanized mouse models. They are infused with various cell types to cure infectious diseases. With the growing prevalence of infectious diseases around the globe, the demand for cell-based humanized mouse models is expected to increase during the forecast period. Furthermore, product innovations are driving the demand for cell-based humanized mouse models. For instance, JAX offers models such as the Hu-CD34-NSG and Hu-CD34-SGM3, which are suited for the long-term study of infectious diseases. Thus, due to the growth in the number of applications of cell-based humanized mouse models, their adoption is expected to increase during the forecast period. 

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

Europe is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Another region offering significant growth opportunities to market players is North America. As developed healthcare systems can be found in nations like the US and Canada, North America held the top position in terms of revenue in 2022. One of the main factors influencing the market in North America is the high cost of healthcare research. 

Furthermore, the region is characterized by the presence of vendors such as Taconic, JAX, Champions Oncology Inc. (Champions Oncology), HuMurine Technologies (HuMurine), and ingenious targeting laboratories. High vendor penetration in the US and Canada will increase product availability and sales. Hence, such factors will fuel the regional market growth during the forecast period.

Buy Full Report Now

Key Humanized Mouse Model Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Altogen labs: The company offers humanized mouse model which are commonly used to test out cancer therapies and drugs, as they are relatively cheap and efficient when compared to humans.

  • Aragen Life Sciences Pvt. Ltd.
  • Biocytogen, BioSafety Research Center Inc.
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • Creative Biolabs
  • Cyagen Biosciences
  • Gempharmatech Co. Ltd.
  • genOway
  • HBM Holdings Ltd.
  • Hera Biolabs Inc.
  • ingenious targeting laboratory, Inotiv, Inc.
  • JANVIER LABS
  • JSR Corp.
  • Oncodesign SA
  • Ozgene Pty Ltd.
  • PerkinElmer Inc.
  • Pharmatest services

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Humanized Mouse Model Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing the market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Humanized Mouse Model Market Drivers

The growing adoption of personalized medicine is notably driving market growth. A new area of medicine is personalized medicine, also known as precision medicine or individualized medicine. To determine the best course of action for each patient, it pinpoints specific biomarkers. Cancer treatment personalized medicine has been created by using mice. The PDX cancer model has been developed by researchers. Several identical mice with compromised immune systems are infused with various tumor-related components from the patient. Each therapy is administered to a different mouse, and each therapy is then evaluated. The patient would then receive therapy that shrinks the tumor.

Moreover, the use of humanized mouse models will rise in response to the rising demand for personalized medicine. For instance, acute myeloid leukemia (AML) and bladder, breast, lung, pancreatic, and ovarian cancers are just a few of the conditions for which Jackson Laboratory has created more than 450 distinct PDX oncology mouse models. Moreover, the advancement of personalized medicine has accelerated as a result of improvements in scientific research and related tools and technologies. Hence, these factors are expected to drive the growth of the market during the forecast period.

Significant Humanized Mouse Model Market Trends

Strategic alliances of vendors is the primary trend shaping market growth. Market players are focusing on developing new strategies to gain a competitive advantage and retain their dominant position. In addition, they are focusing on partnerships to improve their product offerings and expand their customer base via new distribution channels. Some recent strategic alliances in the global humanized mouse model market include:

For instance, in May 2021, Heligenics, Inc. signed a new collaboration with The Jackson Laboratory (JAX). This collaboration includes licensing a custom Heligenics Gene Mutation/Function ERBB2 library for the JAX clinical knowledge base. Thus, such factors are expected to drive the growth of the market during the forecast period.

Major Humanized Mouse Model Market Challenges

Limitations of humanized mouse models is a challenge that affects market growth. Humanized mouse models are extensively used for HIV and cancer research. However, to date, the current models that have been developed have major scientific drawbacks, which are affecting their adoption. During multiple research studies, these models do not correctly exhibit genetic and proteomic responses. These irregularities contribute to the generation of incorrect insights, which affects the outcomes of experiments. Moreover, mouse models have also been found to be ineffective in three conditions, which include burns, sepsis, and trauma. Researchers have constantly expressed concerns about the significant spending on humanized mouse models, which were ineffective for certain diseases. 

However, although mouse models have contributed significantly to HIV and cancer research, some models still lack the ability to address common human conditions such as sepsis and trauma. When they elicit different genomic responses from humans, the treatment response is also altered. In most cases, when the supposed cure is induced in humans, it may lead to fatal responses. Thus, to avoid the loss of money, time, and patient pool, researchers may look for other methods to cure such diseases, which impede the growth of the market during the forecast period.

Buy Now Full Report

Key Humanized Mouse Model Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Humanized Mouse Model Market Customer Landscape

Segment Overview

The humanized mouse model market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • End-user Outlook
    • Pharmaceutical and biotechnology companies
    • CROs
    • Academic and research institutions
  • Product Outlook
    • Genetically humanized mouse model
    • Cell-based humanized mouse model
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Argentina
      • Brazil 
      • Australia

Humanized Mouse Model Market Scope

Report Coverage

Details

Page number

160

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 10.22%

Market Growth 2024-2028

USD 108.6 million

Market structure

Fragmented

YoY growth 2023-2024(%)

9.72

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

Europe at 34%

Key countries

US, UK, France, China, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., genOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv, Inc., JANVIER LABS, JSR Corp., Oncodesign SA, Ozgene Pty Ltd., PerkinElmer Inc., and Pharmatest services

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Humanized Mouse Model Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the humanized mouse model market between 2024 and 2028
  • Precise estimation of the humanized mouse model market size and its contribution of the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of humanized mouse model market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global humanized mouse model market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global humanized mouse model market 2018 - 2022 ($ million)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.3 Product Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
    • 6.4 CROs - Market size and forecast 2023-2028
      • Exhibit 38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on CROs - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
    • 6.5 Academic and research institutions - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 48: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
    • 7.2 Comparison by Product
      • Exhibit 50: Chart on Comparison by Product
      • Exhibit 51: Data Table on Comparison by Product
    • 7.3 Genetically humanized mouse model - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
    • 7.4 Cell-based humanized mouse model - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 60: Market opportunity by Product ($ million)
      • Exhibit 61: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 UK - Market size and forecast 2023-2028
      • Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.9 France - Market size and forecast 2023-2028
      • Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Altogen labs
              • Exhibit 111: Altogen labs - Overview
              • Exhibit 112: Altogen labs - Product / Service
              • Exhibit 113: Altogen labs - Key offerings
            • 12.4 Aragen Life Sciences Pvt. Ltd.
              • Exhibit 114: Aragen Life Sciences Pvt. Ltd. - Overview
              • Exhibit 115: Aragen Life Sciences Pvt. Ltd. - Product / Service
              • Exhibit 116: Aragen Life Sciences Pvt. Ltd. - Key news
              • Exhibit 117: Aragen Life Sciences Pvt. Ltd. - Key offerings
            • 12.5 Biocytogen
              • Exhibit 118: Biocytogen - Overview
              • Exhibit 119: Biocytogen - Product / Service
              • Exhibit 120: Biocytogen - Key offerings
            • 12.6 BioSafety Research Center Inc.
              • Exhibit 121: BioSafety Research Center Inc. - Overview
              • Exhibit 122: BioSafety Research Center Inc. - Product / Service
              • Exhibit 123: BioSafety Research Center Inc. - Key offerings
            • 12.7 Champions Oncology Inc.
              • Exhibit 124: Champions Oncology Inc. - Overview
              • Exhibit 125: Champions Oncology Inc. - Product / Service
              • Exhibit 126: Champions Oncology Inc. - Key news
              • Exhibit 127: Champions Oncology Inc. - Key offerings
            • 12.8 Charles River Laboratories International Inc.
              • Exhibit 128: Charles River Laboratories International Inc. - Overview
              • Exhibit 129: Charles River Laboratories International Inc. - Business segments
              • Exhibit 130: Charles River Laboratories International Inc. - Key news
              • Exhibit 131: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 132: Charles River Laboratories International Inc. - Segment focus
            • 12.9 Creative Biolabs
              • Exhibit 133: Creative Biolabs - Overview
              • Exhibit 134: Creative Biolabs - Product / Service
              • Exhibit 135: Creative Biolabs - Key offerings
            • 12.10 Cyagen Biosciences
              • Exhibit 136: Cyagen Biosciences - Overview
              • Exhibit 137: Cyagen Biosciences - Product / Service
              • Exhibit 138: Cyagen Biosciences - Key offerings
            • 12.11 Gempharmatech Co. Ltd.
              • Exhibit 139: Gempharmatech Co. Ltd. - Overview
              • Exhibit 140: Gempharmatech Co. Ltd. - Product / Service
              • Exhibit 141: Gempharmatech Co. Ltd. - Key offerings
            • 12.12 genOway
              • Exhibit 142: genOway - Overview
              • Exhibit 143: genOway - Product / Service
              • Exhibit 144: genOway - Key offerings
            • 12.13 HBM Holdings Ltd.
              • Exhibit 145: HBM Holdings Ltd. - Overview
              • Exhibit 146: HBM Holdings Ltd. - Product / Service
              • Exhibit 147: HBM Holdings Ltd. - Key offerings
            • 12.14 Hera Biolabs Inc.
              • Exhibit 148: Hera Biolabs Inc. - Overview
              • Exhibit 149: Hera Biolabs Inc. - Product / Service
              • Exhibit 150: Hera Biolabs Inc. - Key offerings
            • 12.15 ingenious targeting laboratory
              • Exhibit 151: ingenious targeting laboratory - Overview
              • Exhibit 152: ingenious targeting laboratory - Product / Service
              • Exhibit 153: ingenious targeting laboratory - Key offerings
            • 12.16 JSR Corp.
              • Exhibit 154: JSR Corp. - Overview
              • Exhibit 155: JSR Corp. - Business segments
              • Exhibit 156: JSR Corp. - Key offerings
              • Exhibit 157: JSR Corp. - Segment focus
            • 12.17 PerkinElmer Inc.
              • Exhibit 158: PerkinElmer Inc. - Overview
              • Exhibit 159: PerkinElmer Inc. - Business segments
              • Exhibit 160: PerkinElmer Inc. - Key news
              • Exhibit 161: PerkinElmer Inc. - Key offerings
              • Exhibit 162: PerkinElmer Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 163: Inclusions checklist
                • Exhibit 164: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 165: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 166: Research methodology
                • Exhibit 167: Validation techniques employed for market sizing
                • Exhibit 168: Information sources
              • 13.5 List of abbreviations
                • Exhibit 169: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              humanized mouse model market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis